Carregant...

Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken

Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Microb Pathog
Autors principals: Matoo, Javaid Jeelani, Bashir, Khalid, Kumar, Ajay, Krishnaswamy, Narayanan, Dey, Sohini, Chellappa, Madhan Mohan, Ramakrishnan, Saravanan
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/
https://ncbi.nlm.nih.gov/pubmed/29635053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!